Last Price
1.13
Today's Change
-0.01 (0.87%)
Day's Change
1.10 - 1.15
Trading Volume
235,500
Market Cap
3 Million
Shares Outstanding
3 Million
Avg Volume
4,863,217
Avg Price (50 Days)
1.47
Avg Price (200 Days)
35.02
PE Ratio
-0.05
EPS
-24.16
Earnings Announcement
15-May-2024
Previous Close
1.14
Open
1.14
Day's Range
1.109 - 1.15
Year Range
0.85 - 200.0
Trading Volume
248,661
1 Day Change
-0.88%
5 Day Change
1.80%
1 Month Change
-20.42%
3 Month Change
4.63%
6 Month Change
-88.11%
Ytd Change
-63.90%
1 Year Change
-99.32%
3 Year Change
-99.99%
5 Year Change
-99.99%
10 Year Change
-99.99%
Max Change
-99.99%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.